Physician profile
Adil Ali
NPI 1730213240
$1,705.82
in general payments reported to CMS, 2019-2025
21 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $124 · 2022: $58.59 · 2023: $317 · 2024: $434 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $800.24 | 2022-2025 | Botox, Ubrelvy |
| Merz Pharmaceuticals, LLC | $208.87 | 2023-2025 | Xeomin |
| Allergan, INC. | $92.01 | 2019-2020 | |
| Amgen INC. | $77.76 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $75.04 | 2024-2025 | Jynarque, Nuedexta |
| Scilex Pharmaceuticals INC. | $56.63 | 2019 | |
| Merz North America, INC. | $45.88 | 2019-2020 | |
| Pacira Therapeutics, INC. | $42.44 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $42.07 | 2023 | Austedo Xr |
| Trice Medical, INC. | $37.30 | 2024 | |
| Medtronic USA, INC. | $34.95 | 2020 | |
| Bioventus LLC | $26.78 | 2019-2020 | |
| Revance Therapeutics, INC. | $25.43 | 2024 | Daxxify |
| Medtronic, INC. | $25.01 | 2023 | Synchromedii |
| Ferring Pharmaceuticals INC. | $21.91 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $19.37 | 2020 | |
| Piramal Critical Care | $16.52 | 2025 | |
| Fidia Pharma USA INC. | $16.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.35 | 2020 | |
| Ermi LLC | $13.35 | 2019 | |
| Depuy Synthes Sales INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.